Strategies to prevent hepatitis B virus reactivation in patients receiving immunosuppressive therapy
Journal
Hepatology
Journal Volume
50
Journal Issue
2
Pages
654-655
Date Issued
2009
Author(s)
SDGs
Other Subjects
entecavir; hepatitis B surface antigen; immunosuppressive agent; lamivudine; rituximab; tenofovir; antiviral therapy; hepatitis B; Hepatitis B virus; high risk patient; human; immune system; immunocompetence; immunosuppressive treatment; letter; lymphoma; priority journal; remission; side effect; toxic hepatitis; treatment duration; virus mutation; virus reactivation; chemically induced disorder; hepatitis B; recurrent disease; Hepatitis B; Humans; Immunosuppressive Agents; Recurrence
Publisher
John Wiley and Sons Ltd
Type
letter